| Literature DB >> 31181634 |
Guirong Sun1, Fang Li2, Xiangfei Ma3, Junwei Sun4, Ruirui Jiang5, Yadong Tian6, Ruili Han7, Guoxi Li8, Yanbin Wang9, Zhuanjian Li10, Xiangtao Kang11, Wenting Li12.
Abstract
Intramuscular fat (IMF) is the most important evaluating indicator of chicken meat quality, the content of which is positively correlated with tenderness, flavor, and succulence of the meat. Chicken IMF deposition process is regulated by many factors, including genetic, nutrition, and environment. Although large number of omics' studies focused on the IMF deposition process, the molecular mechanism of chicken IMF deposition is still poorly understood. In order to study the role of miRNAs in chicken intramuscular adipogenesis, the intramuscular adipocyte differentiation model (IMF-preadipocytes and IMF-adipocytes) was established and subject to miRNA-Seq. A total of 117 differentially expressed miRNAs between two groups were obtained. Target genes prediction and functional enrichment analysis revealed that eight pathways involved in lipid metabolism related processes, such as fatty acid metabolism and fatty acid elongation. Meanwhile a putative miRNA, gga-miR-18b-3p, was identified be served a function in the intramuscular adipocyte differentiation. Luciferase assay suggested that the gga-miR-18b-3p targeted to the 3'UTR of ACOT13. Subsequent functional experiments demonstrated that gga-miR-18b-3p acted as an inhibitor of intramuscular adipocyte differentiation by targeting ACOT13. Our findings laid a new theoretical foundation for the study of lipid metabolism, and also provided a potential target to improve the meat quality in the poultry industry.Entities:
Keywords: ACOT13; differentiation; intramuscular adipocytes; miR-18b-3p
Mesh:
Substances:
Year: 2019 PMID: 31181634 PMCID: PMC6627633 DOI: 10.3390/cells8060556
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Primer sequences used for qPCR in this study.
| Gene | Acc. # | Forward Primer Sequence 5’-3′ | Reverse Primer Sequence 5′-3′ |
|---|---|---|---|
| ACOT13 |
| CTTTGGAACAGCAGCACAGTT | TTACAGGAACCCTTCACTGCC |
|
|
| CAGCCAGCCATGGATGATGA | ACCAACCATCACACCCTGAT |
| siRNA |
| GCACGUUACACGGAGGUUUTTAAACCUCCGUGUAACGUGCTT | |
|
|
| AAGGAGATCGAGGCCTTAGTG | GCCGTCCACGATGAACAAAG |
|
|
| AAAGAAGACAGTGGCAACCG | TCACCATCGAGAAACACTGC |
|
|
| CACTGCCATGATGGTCCCCTA | CCACAAGGAGATGCTGAAGAA |
|
|
| AGTAAGCTCTCAGAAACTTTGTTG | GTCATTTCACTTCACGCAGCA |
|
|
| GCAAGCCCTTCAACGAGATCA | GGGACGATCTCCACACAGG |
|
|
| TTCTACGAGGTCGATTCCCG | AGCCTCTCTGTAGCCGTAG |
|
|
| ATGTGCGACCAGTTTGT | TCACCATTGATGCTGATAG |
| PPARG |
| GTGCAATCAAAATGGAGCC | CTTACAACCTTCACATGCAT |
| ACOT13(CDS) |
| CCCAAGCTTGCCACCATGGGCAGCATGCGCTTCAC | CCGGAATTCCTGTCCTATGTACTTTGTAT |
| WT-ACOT13 |
| CCGCTCGAGAAGCAACTCACCCTTCAGGC | ATTTGCGGCCGCAGCTTGCTTCACACTTCCCAT |
| MUT-ACOT13 |
| CTTACTAATTGTTCCGTAGGTCCCGTCAGAAGGGTTCCTGTAAGCAAC | GTTGCTTACAGGAACCCTTCTGACGGGACCTACGGAACAATTAGTAAG |
Figure 1Introduction of intramuscular preadipocytes in vitro. (A) IMF (intramuscular fat)-preadipocytes. (B) Oil Red O staining of IMF-preadipocytes. (C) IMF-adipocytes. (D) Oil Red O staining of IMF-adipocytes. (E) Triacylglycerol (TG) content of IMF-preadipocytes and IMF-adipocytes group. Data is shown as mean ± SE. ** p < 0.01.
Figure 2Small RNA sequencing and analysis of differentially expressed miRNAs. (A) Distribution of the length and abundance of small RNA sequences in chicken adipocytes. (B) Differential expression of miRNA in IMF-preadipocytes overlapping with that in IMF-adipocytes. (C,D) Volcano plot and heatmap of differentially expressed miRNAs between preadipocytes and adipocytes. (E) Verification of sequencing results by qPCR.
Figure 3Functional enrichment analysis of target genes. (A) KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis on targets of differentially expressed miRNAs. (B) Identified KEGG pathways related to lipid metabolism. (C) Interactive network for differentially expressed miRNAs and their targets.
The eight significantly-enriched pathways related to lipid metabolism.
| Pathway ID | Pathway Term | Target Gene List |
|---|---|---|
| gga00062 | Fatty acid elongation | ELOVL5, HACD3, HADHA, ACAA2, ELOVL4, HACD1, ECHS1, ELOVL1, HSD17B12, MECR, PPT1, ACOT7, HACD2, ELOVL6 |
| gga00020 | Citrate cycle | DLD, IDH3B, IDH3A, SDHA, ACLY, SUCLG2, SUCLG1, ACO2, MDH1, IDH1, ACO1, OGDH, SDHB, IDH3G, IDH2, CS |
| gga01212 | Fatty acid metabolism | ELOVL5, HACD3, ACADS, EHHADH, HADHA, ACAA2, SCD5, FASN, ACSBG2, ACOX1, HACD1, ACSBG1, ECHS1, SCD, HSD17B12, MECR, PPT1, ACSL1, PECR, CPT2, HACD2, |
| ACADSB, ACADL, ELOVL6 | ||
| gga00071 | Fatty acid degradation | ACADS, EHHADH, HADHA, ACAA2, ACSBG2, ACOX1, ECI1, ACSBG1, ECHS1, ACSL1, CPT2, ALDH7A1, ECI2, ACADSB, ACADL |
| gga04010 | MAPK (mitogen-activated protein kinase) signaling pathway | RELA, CHUK, TAOK3, BDNF, EGFR, TNFSF6, PAK1, ChALK5, TAB1, TGFB3, ARR3, RAC2, MAP2K1, NF1, FOS, MAP3K13, PRKCA, CRKL, DUSP6, SRF, CACNG5, GADD45A, FGFR4, MAP3K14, HSPA2, NRAS, cRac1B, PDGF-A,CACNA1D, CASP3, CDC42, MAPK10, STK4, PTPN7, TGFBR2, RPS6KA5, FGF1, DUSP4, GNG12, DUSP7, MAP3K1, NR4A1, HSPA8, LAMTOR3, PPP3CB, TAOK1, MRAS, CACNA1S, MAP2K5, MAPK11, PPP3R1, NFATC3, DUSP10, CACNA1G, RPS6KA, DUSP3, cRac1A, FLNB, CACNA2D1, H-RAS, GADD45B, PPM1B, MAPKAPK3, CACNA1B, TNFRSF1A, BRAF, FGFR1, NFKB2, FGFR3, MAP3K5, CACNG4, FGF8, MAPK9, CACNG3, MAP2K3 |
| gga04150 | mTOR (mammalian target of rapamycin) signaling pathway | CHUK, ATP6V1G1, PDPK1, SLC7A5, STRADA, RNF152, PIK3R5, FZD5, MAP2K1, CAB39L, RPS6KB1, WDR24, SKP2,PRKCA, ATP6V1G3, NPRL2, WNT6, STK11, FZD6, FZD9, SLC38A9, ATP6V1B2, RPS6, FZD4, NRAS, WDR59, MLST8, Wnt8c, RRAGC, PIK3CB, PIK3CD, RRAGD, LAMTOR3, FZD3, ATP6V1A, RPTOR, ULK3, ATP6V1D, CLIP1, WNT11, RPS6KA, PRKAA1,HRAS, EIF4E2, PRKAA2, TNFRSF1A, BRAF, RHOA, TBC1D |
| gga00061 | Fatty acid biosynthesis | FASN, ACSBG2, ACSBG1, ACSL1, ACOT13 |
| gga03320 | PPAR (peroxisome proliferator-activated receptors) signaling pathway | FABP5, PDPK1, EHHADH, FABP3, LXR, PLIN2, SCD5, ACSBG2, LPL, ACOX1, SLC27A2, ACSBG1, SCD, ACSL1, CPT2, CYP8B1, PLIN1, ACADL |
Figure 4The ACOT13 gene was a potential target gene of miR-18-3p. (A) Cluster analysis showed miR-18b-3p was conserved in various species. (B) Conservatism analysis of the miR-18b-3p seed region. (C) The interaction of miR-18b-3p and ACOT13 was predicted based on miRCat. (D) Expression of miR-18b-3p and ACOT13 in pre-differentiation (0 day) and post-differentiation (10 days).
Figure 5miR-18b-3p inhibited adipocyte differentiation by targeting ACOT13. (A) The expression level of miR-18b-3p and marker genes of adipocyte differentiation after miR-18b-3p overexpression. (B) Number of lipid droplets with miR-18b-3p overexpression. (C) The concentration of intracellular triglyceride in the miR-18b-3p overexpressing group was significantly lower. (D) Verification of miR-18b-3p target gene using luciferase assay.
Figure 6Overexpression of ACOT13 promoted adipocyte differentiation in intramuscular adipocytes. (A) ACOT13 expression level was induced in the ACOT13 overexpressing group. (B) Levels of ACOX1, ACOX3, ATGL, PPARG, and FABP4 mRNAs increased after ACOT13 overexpression. (C) Overexpression of the ACOT13 gene increased the lipid droplet formation in intramuscular adipocytes by Oil Red O staining. (D) In the ACOT13 overexpressing group, triacylglycerol synthesis was increased. * p < 0.05; ** p < 0.01.
Figure 7Knockdown of ACOT13 inhibited adipocyte differentiation in intramuscular adipocytes. (A) ACOT13 levels were reduced by the si-ACOT13. (B) Levels of ACOX3, ATGL, PPARD, and FABP4 mRNAs decreased after transfection with si-ACOT13. (C) si-ACOT13 decreased the lipid droplet formation in intramuscular adipocytes by Oil Red O staining. (D) After transfection of si-ACOT13, triacylglycerol synthesis was decreased. * p < 0.05; ** p < 0.01.
Figure 8Rescue experiment of ACOT13, co-transfecting with miR-18b-3p mimics and ACOT13 overexpression. (A) Lipid droplet formation between groups. (B) Triacylglycerol content between groups.
Figure 9Proposed model of gga-miR-18b-3p regulation on intramuscular adipocyte differentiation.